API INTERMEDIATES
Intermediates of Etoricoxib
Below is a list of Etoricoxib intermediates we currently offer. Click on the name of each intermediate to view detailed information specific to your requirements.
If you cannot locate the specific Etoricoxib intermediate you need on this page, you can submit a sourcing request by sending us the intermediate's CAS No. and name. We will respond promptly with further details. To make a request, please click here to send an email.
For any inquiries about upstream or downstream intermediates related to your Etoricoxib requirements, please feel free to reach out. Based on your specifications, we can help source a reliable manufacturer, supplier, or principal who meets the quality standards you require.
| S. No | Product Name | CAS No. | Product Details |
|---|---|---|---|
| 1 | 1-(6-Methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone | 221615-75-4 | View |
| 2 | 2-Chloro-1,3-bis(dimentylamino)trimethinium hexafluorophosphate | 249561-98-6 | View |
| 3 | 4-Chlorobenzaldehyde | 104-88-1 | View |
| 4 | 4-(Methylthio)benzaldehyde | 3446-89-7 | View |
| 5 | Methyl 6-methylnicotinate | 5470-70-2 | View |
| 6 | 4-Methylbenzyl thiocyanate | 18991-39-4 | View |
| 7 | 4-Methylsulphonylphenylacetic acid | 90536-66-6 | View |
| 8 | 5-Formyl-2-methylpyridine | 53014-84-9 | View |
| 9 | 2-CHLORO-1,3-DIMETHYLAMINO TRIMETHINIUM HEXAFLUOROPHOSPHATE | 291756-76-8 | View |
Send us your Intermediates inquiries to bdteam@sspharma.com
- • Products protected by valid patents from a manufacturer are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk
- • Products currently covered by valid US Patents are offered for R&D use from a manufacturer in accordance with 35 USC 271 +A13(1)
- • Products falling in to controlled substance category / list of schedule drugs shall be exported directly from the manufacturer principals only against receipt of original import permission issued by concerned authorities of the importing country.
- • SS Pharma Group assumes no responsibility/liability in case of being imparted with goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer. SS Pharma Group makes no representations or warranties of any kind, express or implied, about the originality or reliability with respect to the intellectual property which includes patents of a manufacturer in its products or services for any purpose.
- • SS Pharma Group warns the sellers not to sell any goods which infringe intellectual property in any manner whatsoever which includes patent rights of any individual or a manufacturer.
- • SS Pharma Group warns the buyers not to use/procure any goods from a manufacturer to achieve a product which might be knowingly causing an infringement of intellectual property in any manner whatsoever which includes patent rights of any individual manufacturer.
- • This website is updated and maintained by SS Pharma Group. As a matter of policy, SS Pharma Group does not entertain any anonymous or pseudonymous inquiries.
Under Development
| S# | Product Name | Therapeutic Area | QUOTE |
|---|---|---|---|
| 1 | Brivaracetam | Anticonvulsant |  |
| 2 | Bempedoic Acid | Anticoagulant | |
| 3 | Esomeprazole | Gastro-Intestinal | |
| 4 | Levetiracetam | Anticonvulsant | |
| 5 | Ranolazine | Anticoagulant | |
| 6 | Ropinirole Hydrochloride | Antiparkinson | |
| 7 | Rosuvastatin Calcium | Antilipidemic | |
| 8 | Sulindac | Anti-Inflammatory | |
| 9 | Ticagrelor | Anticoagulant | |
| 10 | Varenicline Tartrate | Anti-Smoking | |